Syneos health, inc. (SYNH)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Revenue

4,675,815

4,390,116

2,672,064

1,610,596

1,399,239

1,178,799

995,090

868,600

Costs and operating expenses:
Costs and operating expenses:
Direct costs (exclusive of depreciation and amortization)

-

-

-

-

542,404

515,059

432,261

389,056

Selling, general, and administrative expenses

446,281

406,305

282,620

172,386

156,609

145,143

117,890

109,428

Restructuring and other costs

42,135

50,793

33,315

13,612

1,785

6,192

11,828

35,380

Transaction and integration-related expenses

61,275

64,841

123,815

3,143

1,637

7,902

508

-

Asset impairment charges

0

0

30,000

0

3,931

17,245

0

-

Transaction expenses

-

-

-

-

-

-

-

0

Goodwill and intangible assets impairment

-

-

-

-

-

-

-

4,000

Depreciation

76,532

72,158

44,407

21,353

18,140

21,619

19,175

19,915

Amortization

165,933

201,527

135,529

37,851

37,874

32,924

39,298

58,896

Total operating expenses

4,438,061

4,229,934

2,700,930

1,455,237

1,246,879

1,115,155

963,632

906,130

Income from operations

237,754

160,182

-28,866

155,359

152,360

63,644

31,458

-37,530

Other (income) expense, net:
Interest income

7,542

3,686

1,182

216

192

249

310

239

Interest expense

129,820

130,701

63,725

12,016

15,640

53,036

60,799

62,246

Loss on extinguishment of debt

10,395

-4,153

-622

-439

-9,795

-46,750

0

0

Other (income) expense, net

-24,162

28,244

-19,846

-9,002

3,857

7,689

-1,649

4,679

Total other expense, net

-136,045

-102,924

-83,011

-21,241

-21,386

-91,848

-62,138

-57,328

Income (loss) before provision for income taxes

101,709

57,258

-111,877

134,118

130,974

-28,204

-30,680

-94,858

Income tax expense

-29,549

32,974

26,592

21,488

13,927

-4,734

10,849

-35,744

Net income (loss)

131,258

24,284

-138,469

112,630

117,047

-23,470

-41,529

-59,114

Class C common stock dividends

-

-

-

-

-

375

500

500

Net income (loss) attributable to common shareholders

-

-

-

-

-

-27,220

-42,029

-59,614

Earnings (loss) per share:
Basic (USD per share)

1.27

0.23

-1.85

2.08

2.02

-0.51

-0.81

-1.14

Diluted (USD per share)

1.25

0.23

-1.85

2.03

1.95

-0.51

-0.81

-1.14

Weighted average common shares outstanding:
Basic (in shares)

103,618

103,414

74,913

54,031

57,888

53,301

52,009

52,203

Diluted (in shares)

105,005

104,701

74,913

55,610

60,146

53,301

52,009

52,203

Revenue
Revenue

4,675,815

4,390,116

1,852,843

1,030,337

914,740

809,728

652,418

579,145

Direct costs (exclusive of depreciation and amortization) and Reimbursable out-of-pocket expenses

3,645,905

3,434,310

1,232,023

626,633

-

-

-

-

Reimbursable out-of-pocket expenses
Revenue

0

0

819,221

580,259

484,499

369,071

342,672

289,455

Direct costs (exclusive of depreciation and amortization) and Reimbursable out-of-pocket expenses

0

0

819,221

580,259

-

-

-

-